Comparison of induced and spontaneous sputum in the diagnosis of lung cancer

O. Kacmaz Basoglu, A. Atasever, O. Oz Ersoy, F. Bacakoglu, A. Veral (Izmir, Turkey)

Source: Annual Congress 2001 - Lung cancer diagnosis
Session: Lung cancer diagnosis
Session type: Thematic Poster Session
Number: 507

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Kacmaz Basoglu, A. Atasever, O. Oz Ersoy, F. Bacakoglu, A. Veral (Izmir, Turkey). Comparison of induced and spontaneous sputum in the diagnosis of lung cancer. Eur Respir J 2001; 16: Suppl. 31, 507

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Induced sputum in the diagnosis of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 299s
Year: 2004

The diagnostic relevance of cytologic examination of induced sputum in lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 299s
Year: 2004

Detection of MAGE-A expression in induced sputum and bronchial lavage fluid of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 362s
Year: 2003

Expression of MAGE in the induced sputum of lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002

Evaluation of the effect of sampling of spontaneous sputum over a prolonged period on the sensitivity for lung cancer
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011


The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Dealys in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004

Early diagnosis of peripheral lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 319s
Year: 2005

Evaluation of the role of bronchoscopy in the diagnosis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

Evaluation of the efficacy of bronchial endoscopy in the diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 60s
Year: 2001

Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009


CEA levels in the serum and induced sputum of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Hyaluronan: A novel sputum marker for the screening and diagnosis of lung cancer patients
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012

Delays in diagnosis of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 298s
Year: 2004

Delays in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

Screening and diagnosis of lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005